Literature DB >> 20064660

Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphism.

S S Almeida1, C C Barros, M R Moraes, F J Russo, A S Haro, T S Rosa, M F Alves, J B Pesquero, A K Carmona, R F P Bacurau, R C Araújo.   

Abstract

Angiotensin I-converting enzyme (ACE) is recognized as one of the main effector molecules involved in blood pressure regulation. In the last few years some polymorphisms of ACE such as the insertion/deletion (I/D) polymorphism have been described, but their physiologic relevance is poorly understood. In addition, few studies investigated if the specific activity of ACE domain is related to the I/D polymorphism and if it can affect other systems. The aim of this study was to establish a biochemical and functional characterization of the I/D polymorphism and correlate this with the corresponding ACE activity. For this purpose, 119 male brazilian army recruits were genotyped and their ACE plasma activities evaluated from the C- and N-terminal catalytic domains using fluorescence resonance energy transfer (FRET) peptides, specific for the C-domain (Abz-LFK(Dnp)OH), N-domain (Abz-SDK(Dnp)P-OH) and both C- and N-domains (Abz-FRK(Dnp)P-OH). Plasma kallikrein activity was measured using Z-Phe-Arg-AMC as substrate and inhibited by selective plasma kallikrein inhibitor (PKSI). Some physiological parameters previously described related to the I/D polymorphism such as handgrip strength, blood pressure, heart rate and BMI were also evaluated. The genotype distribution was II n=27, ID n=64 and DD n=28. Total plasma ACE activity of both domains in II individuals was significantly lower in comparison to ID and DD. This pattern was also observed for C- and N-domain activities. Difference between ID and DD subjects was observed only with the N-domain specific substrate. Blood pressure, heart rate, handgrip strength and BMI were similar among the genotypes. This polymorphism also affected the plasma kallikrein activity and DD group presents high activity level. Thus, our data demonstrate that the I/D ACE polymorphism affects differently both ACE domains without effects on handgrip strength. Moreover, this polymorphism influences the kallikrein-kinin system of normotensive individuals. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064660     DOI: 10.1016/j.npep.2009.12.003

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

Review 1.  The kallikrein-kinin system and oxidative stress.

Authors:  Yukako Kayashima; Oliver Smithies; Masao Kakoki
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

2.  Angiotensin-converting enzyme gene insertion-deletion polymorphism is a risk marker for Alzheimer's disease in a Chinese population: a meta-analysis of case-control studies.

Authors:  Ye Yuan; Jin-hua Piao; Ke Ma; Na Lu
Journal:  J Neural Transm (Vienna)       Date:  2015-01-18       Impact factor: 3.575

Review 3.  The kallikrein-kinin system in diabetic nephropathy.

Authors:  Hirofumi Tomita; Ryan B Sanford; Oliver Smithies; Masao Kakoki
Journal:  Kidney Int       Date:  2012-02-08       Impact factor: 10.612

4.  Polymorphism of the ace gene and the α-actinin-3 gene in adolescent idiopathic scoliosis.

Authors:  Marcelo Wajchenberg; Rafael de Paiva Luciano; Ronaldo Carvalho Araújo; Délio Eulálio Martins; Eduardo Barros Puertas; Sandro Soares Almeida
Journal:  Acta Ortop Bras       Date:  2013-05       Impact factor: 0.513

5.  Different metabolic responses induced by long-term interdisciplinary therapy in obese adolescents related to ACE I/D polymorphism.

Authors:  Sandro S Almeida; Flavia C Corgosinho; Carlos En Amorim; Marcos F Gregnani; Raquel Ms Campos; Deborah Cl Masquio; Priscila L Sanches; Aline P Ganen; João B Pesquero; Ana R Dâmaso; Marco T Mello; Sergio Tufik; Ronaldo C Araújo
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

6.  Aerobic exercise training differentially affects ACE C- and N-domain activities in humans: Interactions with ACE I/D polymorphism and association with vascular reactivity.

Authors:  Cléber Rene Alves; Tiago Fernandes; José Ribeiro Lemos; Flávio de Castro Magalhães; Ivani Credidio Trombetta; Guilherme Barreto Alves; Glória de Fátima Alves da Mota; Rodrigo Gonçalves Dias; Alexandre Costa Pereira; José Eduardo Krieger; Carlos Eduardo Negrão; Edilamar Menezes Oliveira
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Apr-Jun       Impact factor: 1.636

7.  Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.

Authors:  Anna Papadopoulou; Paraskevi C Fragkou; Eirini Maratou; Dimitra Dimopoulou; Antonis Kominakis; Ioanna Kokkinopoulou; Christos Kroupis; Athina Nikolaidou; Georgios Antonakos; Vasiliki Papaevangelou; Apostolos Armaganidis; Argirios Tsantes; Eftychia Polyzogopoulou; Sotirios Tsiodras; Anastasia Antoniadou; Paraskevi Moutsatsou
Journal:  J Med Virol       Date:  2021-11-05       Impact factor: 20.693

8.  The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise.

Authors:  David Vaughan; Felicitas A Huber-Abel; Franziska Graber; Hans Hoppeler; Martin Flück
Journal:  Eur J Appl Physiol       Date:  2013-02-09       Impact factor: 3.078

9.  Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy.

Authors:  S S Almeida; M G Naffah-Mazzacoratti; P B Guimarães; F Wasinski; F E G Pereira; M Canzian; R S Centeno; H Carrete; E M Yacubian; A K Carmona; R F F Vieira; C R Nakaie; R A Sabatini; S R Perosa; R F P Bacurau; T L F Gouveia; G Gallo; M Würtele; E A Cavalheiro; J A Silva; J B Pesquero; R C Araujo
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222

10.  Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.

Authors:  Fabricio Ferreira de Oliveira; Juliana Marília Berretta; Guido Veiga de Almeida Junior; Sandro Soares de Almeida; Elizabeth Suchi Chen; Marilia Cardoso Smith; Paulo Henrique Ferreira Bertolucci
Journal:  Indian J Med Res       Date:  2019-09       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.